Total Payments
$149,630
2024 Payments
$25,772
Companies
19
Transactions
312
Medicare Patients
59
Medicare Billing
$10,111
Payment Breakdown by Category
Other$81,840 (54.7%)
Consulting$29,680 (19.8%)
Travel$28,468 (19.0%)
Food & Beverage$9,607 (6.4%)
Education$35.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,340 | 23 | 38.3% |
| Consulting Fee | $29,680 | 21 | 19.8% |
| Travel and Lodging | $28,468 | 82 | 19.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $13,650 | 10 | 9.1% |
| Honoraria | $10,850 | 5 | 7.3% |
| Food and Beverage | $9,607 | 168 | 6.4% |
| Education | $35.68 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $50,749 | 78 | $0 (2024) |
| Shire North American Group Inc | $44,667 | 89 | $0 (2019) |
| BIOTISSUE HOLDINGS INC. | $21,747 | 27 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $16,385 | 51 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $5,694 | 14 | $0 (2022) |
| TissueTech, Inc. | $3,017 | 10 | $0 (2020) |
| Kala Pharmaceuticals, Inc. | $1,754 | 3 | $0 (2021) |
| Tarsus Pharmaceuticals, Inc. | $1,333 | 5 | $0 (2024) |
| Allergan, Inc. | $1,118 | 9 | $0 (2021) |
| Oyster Point Pharma, Inc. | $1,069 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,772 | 73 | Bausch & Lomb Americas Inc. ($13,341) |
| 2023 | $24,207 | 35 | BIOTISSUE HOLDINGS, INC. ($14,383) |
| 2022 | $29,178 | 40 | Sun Pharmaceutical Industries Inc. ($24,197) |
| 2021 | $15,183 | 30 | SUN PHARMACEUTICAL INDUSTRIES INC. ($13,244) |
| 2020 | $4,823 | 10 | Novartis Pharmaceuticals Corporation ($4,752) |
| 2019 | $20,546 | 47 | Shire North American Group Inc ($15,479) |
| 2018 | $23,124 | 55 | Shire North American Group Inc ($22,873) |
| 2017 | $6,798 | 22 | Shire North American Group Inc ($6,316) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Ophthalmology | ||||||
| 12/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Ophthalmology | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $77.87 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $103.26 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $38.41 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Dry eyes | ||||||
| 11/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.34 | General |
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $53.72 | General |
| 11/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | Cash or cash equivalent | $67.65 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/05/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Food and Beverage | In-kind items and services | $119.88 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $42.69 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $526.76 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $496.19 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $227.98 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $227.98 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $140.93 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $16.75 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $182.34 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $69.93 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 32 | 141 | $18,630 | $6,005 |
| 2022 | 2 | 27 | 78 | $11,490 | $4,107 |
Total Patients
59
Total Services
219
Medicare Billing
$10,111
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 70 | $12,950 | $4,737 | 36.6% |
| 92285 | Photography of content of eyes | Office | 2023 | 16 | 71 | $5,680 | $1,268 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 50 | $9,250 | $3,604 | 39.0% |
| 92285 | Photography of content of eyes | Office | 2022 | 15 | 28 | $2,240 | $502.56 | 22.4% |
About Dr. Tracy Doll, O.D
Dr. Tracy Doll, O.D is a Optometrist healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700991916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tracy Doll, O.D has received a total of $149,630 in payments from pharmaceutical and medical device companies, with $25,772 received in 2024. These payments were reported across 312 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,340).
As a Medicare-enrolled provider, Doll has provided services to 59 Medicare beneficiaries, totaling 219 services with total Medicare billing of $10,111. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Portland, OR
- Active Since 08/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1700991916
Products in Payments
- Cequa (Drug) $50,438
- XIIDRA (Drug) $49,296
- MIEBO (Drug) $15,288
- PROKERA (Device) $5,488
- Prokera (Device) $3,017
- EYSUVIS (Drug) $1,754
- DAILIES (Device) $956.64
- TYRVAYA (Drug) $948.89
- ALPHAGAN P (Drug) $755.71
- BLINK NUTRITEARS (Drug) $500.00
- LUMIGAN (Drug) $264.91
- LOTEMAX SM (Drug) $241.54
- CEQUA (Drug) $219.32
- TearCare (Device) $210.49
- RESTASIS (Drug) $205.31
- XDEMVY (Drug) $197.43
- VYZULTA (Drug) $176.62
- VUITY (Drug) $148.25
- RYZUMVI (Drug) $119.88
- ULTRA (Device) $92.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Portland
Mila Ioussifova, Od, Cns, Faao, OD, CNS, FAAO
Optometrist — Payments: $130,756
Optometrist $130,756
Dr. Blair Lonsberry, Ms, Od, Med, MS, OD, MED
Optometrist — Payments: $102,549
Optometrist $102,549
Dr. Steven Goldstein, Od, OD
Optometrist — Payments: $55,415
Optometrist $55,415
Thomas Barreto, O.d, O.D
Optometrist — Payments: $9,272
Optometrist $9,272
Dr. Randall Riemer, O.d, O.D
Optometrist — Payments: $8,421
Optometrist $8,421
Katherine Hill, O.d, O.D
Optometrist — Payments: $6,032
Optometrist $6,032